Levocarnitine

Generic Name
Levocarnitine
Brand Names
Carnitor
Drug Type
Small Molecule
Chemical Formula
C7H15NO3
CAS Number
541-15-1
Unique Ingredient Identifier
0G389FZZ9M
Background

Constituent of striated muscle and liver. It is used therapeutically to stimulate gastric and pancreatic secretions and in the treatment of hyperlipoproteinemias.

Indication

⑴用于继发性肉碱缺乏症。主要用于慢性肾衰长期血透患者因肉碱缺乏产生的一系列并发症状,临床表现如心肌病、骨骼肌病、心律失常、高脂血症,以及低血压和透析中肌痉挛等。

⑵用于罕见病β-酮硫解酶缺乏症(BKD)和原发性肉碱缺乏症(PCD)。

⑶用于罕见病戊二酸Ⅰ型。

⑷用于维持罕见病同型半胱氨酸血症引起的血液游离肉碱的正常水平。

Associated Conditions
Carnitine Deficiency, Congenital carnitine deficiency, Secondary Carnitine deficiency
Associated Therapies
-

Safety and Effectiveness of Giving Adefovir (Preveon) Plus Other Anti-HIV Drugs to HIV-Infected Patients Who Have Not Responded to Other Anti-HIV Drug Combinations

Not Applicable
Completed
Conditions
First Posted Date
2001-08-31
Last Posted Date
2005-06-24
Lead Sponsor
Gilead Sciences
Registration Number
NCT00002398
Locations
🇺🇸

Gilead Sciences Inc, Foster City, California, United States

Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success With Nelfinavir

Phase 3
Completed
Conditions
First Posted Date
2001-08-31
Last Posted Date
2005-06-24
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
120
Registration Number
NCT00002220
Locations
🇺🇸

Hawaii AIDS Clinical Trial Unit, Honolulu, Hawaii, United States

🇺🇸

LAC / USC Med Ctr / Infectious Diseases, Los Angeles, California, United States

🇺🇸

Med Ctr of Delaware, Wilmington, Delaware, United States

and more 8 locations

A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir

Not Applicable
Completed
Conditions
First Posted Date
2001-08-31
Last Posted Date
2021-11-04
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
300
Registration Number
NCT00000892
Locations
🇺🇸

Cornell Univ Med Ctr, New York, New York, United States

🇺🇸

Mount Sinai Med Ctr, New York, New York, United States

🇺🇸

Univ of Tennessee / E Tennessee Comprehensive Hemophilia Ctr, Knoxville, Tennessee, United States

and more 42 locations

A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients

Phase 2
Completed
Conditions
First Posted Date
2001-08-31
Last Posted Date
2021-10-29
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
475
Registration Number
NCT00000912
Locations
🇺🇸

USC Univ Hosp & Ambulatory Hlth Care Ctr / USC Med Ctr, Los Angeles, California, United States

🇺🇸

Emory Univ, Atlanta, Georgia, United States

🇺🇸

UCLA CARE Ctr, Los Angeles, California, United States

and more 42 locations

The Safety and Effectiveness of Adefovir Dipivoxil in the Treatment of HIV-Infected Patients

First Posted Date
2001-08-31
Last Posted Date
2013-10-01
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
505
Registration Number
NCT00001082
Locations
🇺🇸

North Jersey Community Research Initiative, Newark, New Jersey, United States

🇺🇸

Community Consortium / UCSF, San Francisco, California, United States

🇺🇸

Washington Reg AIDS Prog / Dept of Infect Dis, Washington, District of Columbia, United States

and more 12 locations

The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs

Phase 2
Completed
Conditions
First Posted Date
2001-08-31
Last Posted Date
2021-11-01
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
300
Registration Number
NCT00001087
Locations
🇺🇸

Rush Univ. Med. Ctr. ACTG CRS, Chicago, Illinois, United States

🇺🇸

Cook County Hosp. CORE Ctr., Chicago, Illinois, United States

🇺🇸

Johns Hopkins Adult AIDS CRS, Baltimore, Maryland, United States

and more 3 locations
© Copyright 2024. All Rights Reserved by MedPath